Cover Image
市場調查報告書

全球避孕設備市場 (∼2027年):男性用保險套,女性用保險套,子宮托,海綿,避孕環,皮下/避孕植入,輸尿管內設備 (IUD),荷爾蒙IUD

Global Contraceptive Devices Market Forecast to 2027: Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD

出版商 Visiongain Ltd 商品編碼 602842
出版日期 內容資訊 英文 186 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球避孕設備市場 (∼2027年):男性用保險套,女性用保險套,子宮托,海綿,避孕環,皮下/避孕植入,輸尿管內設備 (IUD),荷爾蒙IUD Global Contraceptive Devices Market Forecast to 2027: Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD
出版日期: 2017年12月20日 內容資訊: 英文 186 Pages
簡介

全球避孕設備市場2016年成為了121億美元規模。一般認為以該市場今後年複合成長率7.5%擴大。

本報告提供全球避孕設備市場相關調查,市場概要和各市場區隔,各地區趨勢,及加入此市場的主要企業的簡介等彙整資料。

第1章 本報告概要

第2章 簡介

第3章 2017∼2027年的市場預測

  • 至2027年的市場預測
  • 2017年的市場趨勢

第4章 至2027年的各類型市場預測

  • 保險套
  • 子宮托
  • 海綿
  • 避孕環
  • 皮下植入/避孕植入
  • 輸尿管內設備/系統

第5章 至2027年的主要國家市場

  • 北美
  • 歐洲
  • 亞太地區
  • 其他各國

第6章 主要企業

  • Bayer AG
  • Reckitt Benckiser Group plc
  • Merck Sharp & Dohme Corp.
  • Church & Dwight Co., Inc.
  • Teva Pharmaceuticals Industries, Ltd.
  • Allergan, PLC.
  • Ansell Limited (Now Humanwell)
  • The Female Health Company (A division of VERU Inc.)
  • Karex Industries
  • Mayer Laboratories
  • Kessel Medintim GmbH
  • okamoto株式會社
  • Agile Therapeutics, Inc.
  • Eurogine S.L.

第7章 定性分析

  • SWOT分析
  • PEST分析

第8章 結論與建議

附錄

目錄
Product Code: PHA0271

The global contraceptive devices market is expected to grow at a CAGR of 7.5% in the first half of the forecast period. In 2016, the market was estimated at $12.1bn and dominated by the condoms submarket followed by the IUD submarket.

How this report will benefit you:

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 186-page report you will receive 67 tables and 84 figures- all unavailable elsewhere.

The 186-page report provides clear detailed insight into the global contraceptive devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Global Contraceptive Devices Market Forecast to 2027

This report also breaks down the revenue forecast for the global contraceptive devices market by type:

  • Condoms: Male and Female
  • Diaphragms
  • Sponges
  • Vaginal Rigs
  • Subdermal/Contraceptive Implants
  • IUDs: Copper IUD and Hormonal IUD

This report provides individual revenue forecasts to 2027 for these regional and national markets:

  • North America: US & Canada
  • Europe: the UK, Germany, France, Italy, Rest of Europe
  • Asia-Pacific: China, Japan, India, Rest of Asia-Pacific
  • Rest of the World (RoW): Latin America, Middle East & Africa

This report discusses the SWOT Analysis and PEST Analysis of the global contraceptive devices market.

Our study discusses the selected leading companies that are the major players in the global contraceptive devices market:

  • Bayer AG
  • Reckitt Benckiser Group plc
  • Merck Sharp & Dohme Corp.
  • Church & Dwight Co., Inc.
  • Teva Pharmaceutical Industries, Ltd.
  • Allergan plc
  • Ansell Limited (Now Humanwell)
  • The Female Health Company (a division of VERU Inc.)
  • Karex Industries
  • Mayer Laboratories
  • Kessel Medintim GmbH
  • Okamato Industries, Inc.
  • Agile Therapeutics, Inc.
  • Eurogine S.L.

Visiongain's study is intended for anyone requiring commercial analyses for the global contraceptive devices market. You find data, trends and predictions.

Buy our report today Global Contraceptive Devices Market Forecast to 2027: Male Condoms, Female Condoms, Diaphragms, Sponges, Vaginal Rings, Subdermal/Contraceptive Implants, Intra-uterine Devices (IUDs), Copper IUD, Hormonal IUD.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Contraceptive Devices Market Overview
  • 1.2. Overview of Findings
  • 1.3. Global Contraceptive Devices Market Segmentation
  • 1.4. Why You Should Read This Report
  • 1.5. How This Report Delivers
  • 1.6. Key Questions Answered by This Analytical Report Include:
  • 1.7. Who is This Report For?
  • 1.8. Methodology
    • 1.8.1. Primary Research
    • 1.8.2. Secondary Research
    • 1.8.3. Market Evaluation & Forecasting Methodology
  • 1.9. Frequently Asked Questions (FAQ)
  • 1.10. Associated Visiongain Reports
  • 1.11. About Visiongain

2. Introduction to the Contraceptive Devices Market

  • 2.1. Contraceptive Devices Market Definition
  • 2.2. Evolution of Contraceptive Devices
    • 2.2.1. Snapshot: Evolution of Contraceptive Devices
    • 2.2.2. Currently Available Contraceptive Devices
    • 2.2.3. Future of Contraceptive Devices
    • 2.2.4. Contraceptive Devices in Development

3. Global Contraceptive Devices Market Forecast to 2027

  • 3.1. Global contraceptive Devices Market Forecast to 2027
  • 3.2. Global Contraceptive Devices Market Dynamics, 2017

4. Global Contraceptive Devices Market by Type: Market Forecast to 2027

  • 4.1. Global Condoms Market Forecast to 2027
  • 4.2. Global Diaphragms Market Forecast to 2027
  • 4.3. Global Sponges Market Forecast to 2027
  • 4.4. Global Vaginal Rings Market Forecast to 2027
  • 4.5. Global Subdermal Implants/ Contraceptive Implant Market Forecast to 2027
  • 4.6. Global Intrauterine Devices/ Systems (IUD's and IUS's) Market Forecast to 2027

5. Leading National Markets Forecast to 2027

  • 5.1. North America Contraceptive Devices Market Forecast to 2027
    • 5.1.1. The U.S. Contraceptive Devices Market Forecast to 2027
    • 5.1.2. Canada Contraceptive Devices Market Forecast to 2027
  • 5.2. Europe Contraceptive Devices Market Forecast to 2027
    • 5.2.1. U.K. Contraceptive Devices Market Forecast to 2027
    • 5.2.2. Germany Contraceptive Devices Market Forecast to 2027
    • 5.2.3. France Contraceptive Devices Market Forecast to 2027
    • 5.2.4. Italy Contraceptive Devices Market Forecast to 2027
    • 5.2.5. Rest of Europe Contraceptive Devices Market Forecast to 2027
  • 5.3. Asia-Pacific Contraceptive Devices Market Forecast to 2027
    • 5.3.1. China Contraceptive Devices Market Forecast to 2027
    • 5.3.2. Japan Contraceptive Devices Market Forecast to 2027
    • 5.3.3. India Contraceptive Devices Market Forecast to 2027
    • 5.3.4. Rest of Asia-Pacific Contraceptive Devices Market Forecast to 2027
  • 5.4. Rest of the World (ROW) Contraceptive Devices Market Forecast to 2027
    • 5.4.1. Latin America Contraceptive Devices Market Forecast to 2027
    • 5.4.2. Middle East & Africa Contraceptive Devices Market Forecast to 2027

6. Leading Companies in the Contraceptive Devices Market

  • 6.1. Bayer AG
    • 6.1.1. Bayer AG: Business Overview
    • 6.1.2. Bayer AG: Financial Overview
    • 6.1.3. Bayer AG: Product Portfolio
    • 6.1.4. Bayer AG - Recent Developments (2014-2017)
    • 6.1.5. Bayer AG - SWOT Analysis
  • 6.2. Reckitt Benckiser Group plc
    • 6.2.1. Reckitt Benckiser Group plc: Business Overview
    • 6.2.2. Reckitt Benckiser Group plc: Financial Overview
    • 6.2.3. Reckitt Benckiser Group plc: Product Portfolio
    • 6.2.4. Reckitt Benckiser Group plc: Recent Developments (2014-2017)
    • 6.2.5. Reckitt Benckiser Group plc: SWOT Analysis
  • 6.3. Merck Sharp & Dohme Corp.
    • 6.3.1. Merck Sharp & Dohme Corp.: Business Overview
    • 6.3.2. Merck Sharp & Dohme Corp.: Financial Overview
    • 6.3.3. Merck Sharp & Dohme Corp.: Product Portfolio
    • 6.3.3. Merck Sharp & Dohme Corp.: SWOT Analysis
  • 6.4. Church & Dwight Co., Inc.
    • 6.4.1. Church & Dwight Co., Inc.: Business Overview
    • 6.4.2. Church & Dwight Co., Inc.: Financial Overview
    • 6.4.3. Church & Dwight Co., Inc.: Product Portfolio
    • 6.4.4. Church & Dwight Co., Inc.: Recent Developments (2014-2017)
  • 6.5. Teva Pharmaceuticals Industries, Ltd.
    • 6.5.1. Teva Pharmaceuticals Industries, Ltd.: Business Overview
    • 6.5.2. Teva Pharmaceuticals Industries, Ltd.: Financial Overview
    • 6.5.3. Teva Pharmaceuticals Industries, Ltd.: Product Portfolio
    • 6.5.4. Teva Pharmaceuticals Industries, Ltd.: Recent Developments (2014-2017)
  • 6.6. Allergan, PLC.
    • 6.6.1. Allergan, PLC.: Business Overview
    • 6.6.2. Allergan, PLC.: Financial Overview
    • 6.6.3. Allergan, PLC.: Product Portfolio
    • 6.6.4. Allergan, PLC.: Recent Developments (2014-2017)
    • 6.6.5. Allergan, PLC.: SWOT Analysis
  • 6.7. Ansell Limited (Now Humanwell)
    • 6.7.1. Ansell Limited (Now Humanwell): Business Overview
    • 6.7.2. Ansell Limited (Now Humanwell): Financial Overview
    • 6.7.3. Ansell Limited (Now Humanwell): Product Portfolio
    • 6.7.4. Ansell Limited (Now Humanwell): Recent Developments (2014-2017)
    • 6.7.5. Ansell Limited (Now Humanwell): SWOT Analysis
  • 6.8. The Female Health Company (A division of VERU Inc.)
    • 6.8.1. The Female Health Company (A division of VERU Inc.): Business Overview
    • 6.8.2. The Female Health Company (A division of VERU Inc.): Financial Overview
    • 6.8.3. The Female Health Company (A division of VERU Inc.): Product Portfolio
    • 6.8.4. The Female Health Company (A division of VERU Inc.): Recent Developments (2014-2017)
  • 6.9. Karex Industries
    • 6.9.1. Karex Industries: Business Overview
    • 6.9.2. Karex Industries: Financial Overview
    • 6.9.3. Karex Industries: Product Portfolio
    • 6.9.4. Karex Industries: Recent Developments (2014-2017)
    • 6.9.5. Karex Industries: SWOT Analysis
  • 6.10. Mayer Laboratories
    • 6.10.1. Mayer Laboratories: Business Overview
    • 6.10.2. Mayer Laboratories: Product Portfolio
  • 6.11. Kessel Medintim GmbH
    • 6.11.1. Kessel Medintim GmbH: Business Overview
    • 6.11.2. Kessel Medintim GmbH: Product Portfolio
    • 6.11.3. Kessel Medintim GmbH: Recent Developments (2014-2017)
  • 6.12. Okamato Industries, Inc.
    • 6.12.1. Okamato Industries, Inc.: Business Overview
    • 6.12.2. Okamato Industries, Inc.: Product Portfolio
  • 6.13. Agile Therapeutics, Inc.
    • 6.13.1. Agile Therapeutics, Inc.: Business Overview
    • 6.13.2. Agile Therapeutics, Inc.: Financial Overview
    • 6.13.3. Agile Therapeutics, Inc.: Product Portfolio
  • 6.14. Eurogine S.L.
    • 6.14.1. Eurogine S.L.: Business Overview
    • 6.14.2. Eurogine S.L.: Product Portfolio

7. Contraceptive Devices Market: Qualitative Analysis

  • 7.1. SWOT Analysis
    • 7.1.1. Global Contraceptive Devices Market Drivers
      • 7.1.1.1. Availability of technologically advanced contraceptive devices
      • 7.1.1.2. Rapidly growing population leading to high risk of sexually transmitted diseases (STDs) & HIV
      • 7.1.1.3. Increasing awareness (campaigns/ programmes) and government initiatives related to contraceptive devices
    • 7.1.2. Global Contraceptive Devices Market Weaknesses
      • 7.1.2.1. Concerns associated with the use of contraceptive devices
      • 7.1.2.2. High cost of contraceptives and increasing pricing pressure on manufacturers
      • 7.1.2.3. Product recalls
    • 7.1.3. Global Contraceptive Devices Market Opportunity
      • 7.1.3.1. Focus on emerging markets
    • 7.1.4. Global Contraceptive Devices Market Trend
      • 7.1.4.1. Development of technologically advanced contraceptive devices
  • 7.2. PEST Analysis
    • 7.2.1. Political
    • 7.2.2. Economic
    • 7.2.3. Social
    • 7.2.4. Technological

8. Conclusions and Recommendations

  • 8.1. The Global Contraceptive Devices Market in 2016, 2017 and 2027
    • 8.1.1. Current Leading Contraceptive Devices Segments
    • 8.1.2. Leading Contraceptive Devices Companies
    • 8.1.3. Leading Regional Markets
  • 8.2. Global Contraceptive Devices Market Forecast 2016-2027
  • 8.3. The Future of the Contraceptive Devices Market?

Appendices

  • Glossary
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Tables

  • Table 2.1: Contraceptive Devices, Pipeline Products, 2017
  • Table 3.1: Global Contraceptive Devices Market Forecast: Revenue($m), AGR(%) and CAGR(%), 2016-2027
  • Table 3.2: Global Contraceptive Devices Market Forecast by Type: Revenue($m), AGR(%) and CAGR(%), 2016-2027
  • Table 3.3: Contraceptive Devices Market Forecast by Geography: Revenue($m), AGR(%) and CAGR(%), 2016-2027
  • Table 4.1: Global Condoms Market Forecast by Gender: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.2: Global Diaphragm Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.3: Global Sponges Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.4: Global Vaginal Rings Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.5: Global Subdermal/ Contraceptive Implant Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 4.6: Global Intrauterine Devices/ System's Market Forecast by type: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.1: Contraceptive Devices Market Forecast Segmented by Regional Market: Revenue($m), AGR(%) and CAGR(%), 2016-2027
  • Table 5.2: North American Contraceptive Devices Market Forecast Segmented by National Market: Revenue($m), AGR(%) and CAGR(%), 2016-2027
  • Table 5.3: U.S. Contraceptive Devices Market Forecast: Revenue($m), AGR(%) and CAGR(%), 2016-2027
  • Table 5.4: Canada Contraceptive Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.5: Europe Contraceptive Devices Market Forecast Segmented by National Market: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.6: U.K. Contraceptive Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.7: Germany Contraceptive Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.8: France Contraceptive Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.9: Italy Contraceptive Devices Market Forecast: Revenue($m), AGR(%) and CAGR(%), 2016-2027
  • Table 5.10: Rest of Europe Contraceptive Devices Market Forecast: Revenue($m, AGR(%), CAGR(%), 2016-2027
  • Table 5.11: Asia-Pacific Contraceptive Devices Market Forecast Segmented by National Market: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.12: China Contraceptive Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.13: Japan Contraceptive Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.14: India Contraceptive Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.15: Rest of Asia-Pacific Contraceptive Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.16: Rest of the World Contraceptive Devices Market Forecast Segmented by National Market: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.17: Latin America Contraceptive Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 5.18: Middle East & Africa Contraceptive Devices Market Forecast: Revenue($m), AGR(%), CAGR(%), 2016-2027
  • Table 6.1: Bayer-Company Overview
  • Table 6.2: Bayer AG-Product Portfolio
  • Table 6.3: Bayer AG-Recent Developments
  • Table 6.4: Reckitt Benckiser Group plc-Company Overview
  • Table 6.5: Reckitt Benckiser Group plc-Product Portfolio
  • Table 6.6: Reckitt Benckiser Group plc-Recent Developments
  • Table 6.7: Merck Sharp & Dohme Corp.- Company Overview
  • Table 6.8: Merck Sharp & Dohme Corp.- Product Portfolio
  • Table 6.9: Church & Dwight Co., Inc.-Company Overview
  • Table 6.10: Church & Dwight Co., Inc.-Product Portfolio
  • Table 6.11: Church & Dwight Co., Inc.-Recent Developments
  • Table 6.12: Teva Pharmaceuticals Industries Ltd.-Company Overview
  • Table 6.13: Teva Pharmaceuticals Industries Ltd.-Product Portfolio
  • Table 6.14: Teva Pharmaceuticals Industries Ltd.-Recent Developments
  • Table 6.15: Allergan Inc.-Company Overview
  • Table 6.16: Allergan Inc.-Product Portfolio
  • Table 6.17: Allergan Inc.-Recent Developments
  • Table 6.18: Ansell-Company Overview
  • Table 6.19: Ansell-Product Portfolio
  • Table 6.20: Ansell-Recent Developments
  • Table 6.21: The Female Health Company-Company Overview
  • Table 6.22: The Female Health Company-Product Portfolio
  • Table 6.23: The Female Health Company-Recent Developments
  • Table 6.24: Karex Industries-Recent Developments
  • Table 6.25: Karex Industries-Product Portfolio
  • Table 6.26: Karex Industries-Recent Developments
  • Table 6.27: Mayer Laboratories-Recent Developments
  • Table 6.28: Mayer Laboratories-Product Portfolio
  • Table 6.29: Kessel Medintim Gmbh-Company Overview
  • Table 6.30: Kessel Medintim Gmbh-Product Portfolio
  • Table 6.31: Kessel Medintim Gmbh-Recent Developments
  • Table 6.32: Okamato Industries, Inc.- Company Overview
  • Table 6.33: Okamato Industries, Inc.- Product Portfolio
  • Table 6.34: Agile Therapeutics, Inc.-Company Overview
  • Table 6.35: Agile Therapeutics, Inc.-Product Portfolio
  • Table 6.36: Eurogine, S.L.-Company Overview
  • Table 6.37: Eurogine, SL-Product Portfolio
  • Table 7.1: List of Product Recalls
  • Table 7.2: Contraceptive Devices Approved and Available in 2016

List of Figures

  • Figure 1.1: Global Contraceptive Devices Market Segmentation Overview, 2017
  • Figure 2.1: Snapshot: Evolution of Contraceptive Devices
  • Figure 3.1: Global Contraceptive Devices Market Forecast: 2016-2027($m, AGR%)
  • Figure 3.2: Global Contraceptive Devices Market Forecast by Type: 2016-2027($m, AGR%)
  • Figure 3.3: Contraceptive Devices Market Forecast by Geography: 2016-2027($m, AGR%)
  • Figure 3.4: Contraceptive Devices Market Dynamics, 2017
  • Figure 4.1: Global Contraceptive Device Market by Type: Market Share(%), 2017
  • Figure 4.2: Global Contraceptive Device Market by Type: Market Share(%), 2022
  • Figure 4.3: Global Contraceptive Device Market by Type: Market Share(%), 2027
  • Figure 4.4: Global Condoms Market Forecast: 2016-2027($m, AGR%)
  • Figure 4.5: Global Condoms Contraceptive Device Market by Gender: Market Share(%), 2017
  • Figure 4.6: Global Condoms Contraceptive Device Market by Gender: Market Share(%), 2022
  • Figure 4.7: Global Condoms Contraceptive Device Market by Gender: Market Share(%), 2027
  • Figure 4.8Global Diaphragms Market Forecast: 2016-2027($m, AGR %)
  • Figure 4.9: Global Sponges Market Forecast: 2016-2027($m, AGR%)
  • Figure 4.10: Global Vaginal Rings Market: 2016-2027($m, AGR %)
  • Figure 4.11: Global Subdermal/ Contraceptive Implant Device Market: 2016-2027($m, AGR%)
  • Figure 4.12: Global Intrauterine Devices/ System's Market Forecast by Type 2016-2027($m, AGR%)
  • Figure 4.13: Global Intrauterine Devices/System's Market by Sub-Segment: Market Share(%), 2017
  • Figure 4.14: Global Intrauterine Devices/ System's Market by Sub-Segment: Market Share(%), 2022
  • Figure 4.15: Global Intrauterine Devices/ System's Market by Sub-Segment: Market Share(%), 2027
  • Figure 5.1: Contraceptive Devices Market Forecast Segmented by Regional Market: 2016-2027($m, AGR %)
  • Figure 5.2: Contraceptive Devices Market by Region: Market Share(%), 2017
  • Figure 5.3: Contraceptive Devices Market by Region: Market Share(%), 2022
  • Figure 5.4: Contraceptive Devices Market by Region: Market Share(%), 2027
  • Figure 5.5: North America Contraceptive Use by Type, 2015
  • Figure 5.6: Europe Contraceptive Use by Type, 2015
  • Figure 5.7: Asia Contraceptive Use by Type, 2015
  • Figure 5.8: Latin America & Caribbean Contraceptive Use by Type, 2015
  • Figure 5.9: Africa Contraceptive Use by Type, 2015
  • Figure 5.10: North American Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 5.11: North American Contraceptive Devices Market Forecast Segmented by National Market: 2016-2027($m, AGR %)
  • Figure 5.12: North American Contraceptive Devices Market by Country: Market Share(%), 2017
  • Figure 5.13: North American Contraceptive Devices Market by Country: Market Share(%), 2022
  • Figure 5.14: North American Contraceptive Devices Market by Country: Market Share(%), 2027
  • Figure 5.15: U.S. Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 5.16: Canada Contraceptive Devices Market Forecast: 2017-2027($m, AGR %)
  • Figure 5.17: Europe Contraceptive Devices Market Forecast: 2016-2027($m, AGR%)
  • Figure 5.18: Europe Contraceptive Devices Market Forecast Segmented by National Market: 2016-2027($, AGR %)
  • Figure 5.19: Europe Contraceptive Devices Market by Country: Market Share(%), 2017
  • Figure 5.20: Europe Contraceptive Devices Market by Country: Market Share(%), 2022
  • Figure 5.21: Europe Contraceptive Devices Market by Country: Market Share(%), 2027
  • Figure 5.22: U.K. Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 5.23: Germany Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 5.24: France Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 5.25: Italy Contraceptive Devices Market Forecast: 2016-2027($m, AGR%)
  • Figure 5.26: Rest of Europe Contraceptive Devices Market Forecast: 2016-2027($m, AGR%)
  • Figure 5.27: Asia-Pacific Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 5.28: Asia-Pacific Contraceptive Devices Market Forecast Segmented by National Market: 2016-2027($m, AGR %)
  • Figure 5.29: Asia-Pacific Contraceptive Devices Market by Country: Market Share(%), 2017
  • Figure 5.30: Asia-Pacific Contraceptive Devices Market by Country: Market Share(%), 2022
  • Figure 5.31: Asia-Pacific Contraceptive Devices Market by Country: Market Share(%), 2027
  • Figure 5.32: China Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 5.33: Japan Contraceptive Devices Market Forecast: 2016-2027($m, AGR%)
  • Figure 5.34: India Contraceptive Devices Market Forecast: 2016-2027($m, AGR%)
  • Figure 5.35: Rest of Asia-Pacific Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 5.36: Rest of the World Contraceptive Devices Market Forecast: 2016-2027($m, AGR%)
  • Figure 5.37: Rest of the World Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 5.38: Rest of the World Contraceptive Devices Market by Country: Market Share(%), 2017
  • Figure 5.39: Rest of the World Contraceptive Devices Market by Country: Market Share(%), 2022
  • Figure 5.40: Rest of the World Contraceptive Devices Market by Country: Market Share(%), 2022
  • Figure 5.41: Latin America Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 5.42: Middle East & Africa Contraceptive Devices Market Forecast: 2016-2027($m, AGR %)
  • Figure 6.1: Bayer AG-Historical Revenue($m), R&D Expenditure(%) 2012-2016, Business Segments and Geographical Segments
  • Figure 6.2: Bayer AG-SWOT Analysis
  • Figure 6.3: Reckitt Benckiser-Historical Revenue($m), R&D Expenditure(%) 2012-2016, Business Segments and Geographical Segments
  • Figure 6.4: Reckitt Benckiser Group plc-SWOT Analysis
  • Figure 6.5: Merck Sharp & Dohme Corp.(A Subsidiary of Merck & Co.)-Historical Revenue($m), R&D Expenditure(%) 2012-2016, Business Segments and Geographical Segments
  • Figure 6.6: Merck Sharp & Dohme Corp.-SWOT Analysis
  • Figure 6.7: Church & Dwight., Inc.-Historical Revenue($m), R&D Expenditure(%) 2012-2016, Business Segments and Geographical Segments
  • Figure 6.8: Teva Pharmaceuticals Industries, Ltd.-Historical Revenue($m), R&D Expenditure(%) 2012-2016, Business Segments and Geographical Segments
  • Figure 6.9: Allergan Inc.-Historical Revenue($m), R&D Expenditure(%) 2012-2016, Business Segments and Geographical Segments
  • Figure 6.10: Allergan, PLC.-SWOT Analysis
  • Figure 6.11: Ansell Ltd.-Historical Revenue($m), R&D Expenditure(%) 2012-2016, Business Segments and Geographical Segments
  • Figure 6.12: Ansell Limited(Now Humanwell)-SWOT Analysis
  • Figure 6.13: The Female Health Company-Historical Revenue($m), R&D Expenditure(%) 2012-2016, Geographical Segments 2016
  • Figure 6.14: Karex Industries-Historical Revenue($m), R&D Expenditure(%) 2012-2016, Business Segments & Geographical Segments
  • Figure 6.15: Karex Industries-SWOT Analysis
  • Figure 6.16: Agile Therapeutics-Historical R&D Revenue
  • Figure 8.1: Global Contraceptive Devices Market, 2016
  • Figure 8.2: Global Contraceptive Devices Market, 2017
  • Figure 8.3: Global Contraceptive Devices Market, 2027
  • Figure 8.4: Global Leading Contraceptive Devices Segments, 2016
  • Figure 8.5: Leading Regional Markets, 2016

Companies Listed

  • 7Med Industrie
  • Actavis PLC.
  • Agile Therapeutics
  • Almirall, S.A
  • Andromaco
  • Ansell Limited
  • Anterion Therapeutics
  • APCOR R&M, Belgium
  • Assembly Biosciences, Inc.
  • Bayer HealthCare
  • Beiersdorf AG
  • BioRings
  • CEMAG
  • Chongqing Medical Equipment Factory Co., Ltd.
  • Church & Dwight, Co. Inc.
  • CITIC Capital
  • CONRAD
  • ContraMed, LLC
  • Cupid Ltd.
  • Evestra, Inc.
  • FEI Technologies
  • Femsays Inc
  • Gedeon Richter Plc.
  • GeSea Biosciences
  • Grunenthal
  • HLL Lifecare Limited
  • HRA Pharma
  • Humanwell
  • Hydra Biosciences
  • Hypermarcs
  • Implementos Plasticos, Ltd., Mexico City
  • Innova Quality S.A.S
  • Karex Berhad
  • Karex Industries
  • Kessel Marketing & Vertriebs GmbH
  • Kessel Medintim Gmbh
  • Mayer Laboratories, Inc
  • Medicines360
  • Merck
  • Merck Sharp & Dohme Corp.
  • Meril Life Science Private Ltd
  • Microchips Biotech, Inc.
  • Mimetogen Pharmaceuticals, Inc.
  • Mona Lisa N.V.
  • Naurex, Inc.
  • OCON Medical Ltd.
  • Okamato Industries
  • Origami Healthcare Products, Inc.
  • Ottawa Hospital Research Institute (OHRI)
  • OvaTech
  • PATH
  • Poly-Med Inc
  • Pregna International Limited
  • ProMed Pharma
  • Prosan International B.V.
  • QPharma
  • Raymond Limited
  • Reckitt Benckiser Group
  • ReProtect Inc.
  • Shanghai Dahua Medical Apparatus Co., Ltd;
  • Shenyang Liren Medical & Technological Co.
  • Shepherd Medical Company
  • SILCS, Inc.
  • Teva Pharmaceuticals, Ltd.
  • The Female Health Company
  • Theramex
  • Tianjin Condombao Medical Polyurethane Tech. Co. Ltd
  • Tianjin Medical Instrument Factory
  • Veru Inc.
  • Vitality Medical Products
  • Yantai Family Planning Medicine & Apparatus Co. Ltd., China
  • Reckitt Benckiser Group, PLC

List of Organizations Mentioned in the Report:

  • Albert Einstein College of Medicine
  • Centre Hospitalier Universitaire de Toulouse
  • CONRAD
  • Contrel Research, Belgium
  • DAIDS
  • FHI 360
  • Harvard University
  • Huazhong University of Science and Technology
  • Institute of Biomedical Engineering at Chinese Academy of Medical College
  • International Partnership for Microbicides
  • ISAF
  • Italian Medical Society for Contraception
  • Murdoch University
  • National Research Institute for Family Planning in Beijing
  • NIAID
  • NICHD
  • Northwestern University
  • Peking University
  • Rockefeller Foundation
  • RTI International; NICHD
  • Shandong Provincial Institute
  • Shandong University
  • Shanghai Institute of Planned Parenthood Research (SIPPR)
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST)
  • Technology for Family Planning
  • Tehran University
  • Tongji Medical College
  • University of California at Berkeley
  • University of Cincinnati
  • University of Helsinki
  • University of Minnesota
  • University of North Carolina at Charlotte
  • University of Washington
  • USAID
  • Weill Cornell Medical College
  • WHO
  • Women's Health Alliance
  • Yale University
Back to Top